Document is current
Any future updates will be listed below
-
Authors
Smith, Emily R. https://orcid.org/0000-0001-5715-9459
Muhihi, Alfa
Wylie, Blair J.
Mugusi, Sabina
Aboud, Said
Bakari, Mohamed
Fawzi, Wafaie
Kinyogoli, Shabani
Oakley, Erin M.
Pan, Qing
Sando, Mary M.
Brownlee, Victoria S.
Pembe, Andrea B.
Sudfeld, Christopher R.
Masanja, Honorati
-
Funding
Funding for this research was provided by:
Bill and Melinda Gates Foundation (INV-044514)
- License Information
-
More Information
Article History
Received: 8 November 2024
Accepted: 27 May 2025
First Online: 14 June 2025
Declarations
:
: The trial protocol was approved by Harvard T. H. Chan School of Public Health Institutional Review Board (Ref. No. IRB22-1581), Columbia University Medical Center (IRB-AAAU7271), the Ifakara Health Institute Institutional Review Board (IHI/IRB/No: 45–2023), the Muhimbili University of Health and Allied Sciences Institutional Review Board (MUHAS-REC-07–2023-1801), the National Health Research Ethics Committee (NatHREC) (Ref. No. NIMR/HQ/R.8a/Vol. IX/4448), Tanzania Commission for Science and Technology (COSTECH) (Permit No. CST00000303-2024–2024-00342) and the Tanzania Medicine and Medical Device Authority (TMDA) (Ref No. BC.69/96/98/01). All participants will provide written informed consent before enrollment into the trial and will have the right to withdraw at any time.
: Not applicable.
: No competing interests to report for any authors or trial staff members.
